Olle Karlström

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. ncbi request reprint Efficacy of nelfinavir-based treatment in the central nervous system of HIV-1 infected patients
    Olle Karlström
    Divisions of Infectious Diseases, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Scand J Infect Dis 38:371-4. 2006
  2. doi request reprint Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapy
    Olle Karlström
    Division of Infectious Diseases, Department of Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden
    AIDS 22:899-901. 2008
  3. ncbi request reprint Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapy
    Olle Karlström
    Department of Infectious Diseases, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
    J Acquir Immune Defic Syndr 44:417-22. 2007

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Efficacy of nelfinavir-based treatment in the central nervous system of HIV-1 infected patients
    Olle Karlström
    Divisions of Infectious Diseases, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Scand J Infect Dis 38:371-4. 2006
    ..Using a highly sensitive method, NFV was detected and quantified in the CSF, although at low values, which could have contributed to the high anti-HIV-1 efficacy of the therapy seen in our subjects...
  2. doi request reprint Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapy
    Olle Karlström
    Division of Infectious Diseases, Department of Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden
    AIDS 22:899-901. 2008
    ..Sustained virological response was achieved in 9/13 (69%) versus 20/26 (77%) patients (intent-to-treat), respectively. The lower-than-standard peg-IFN dose offered high compliance and reasonable sustained virological response rates...
  3. ncbi request reprint Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapy
    Olle Karlström
    Department of Infectious Diseases, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
    J Acquir Immune Defic Syndr 44:417-22. 2007
    ..To investigate the feasibility of ritonavir-boosted atazanavir monotherapy in HIV-1-infected patients with stable antiretroviral therapy (ART)...